Pharmacopeia Drug Discovery (PCOP) Cuts 40% of Jobs; Sees $3 Million Q3 Charge
8/5/2008 6:35:31 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) Earns Milestone Payment From Wyeth (WYE)
7/29/2008 6:33:42 AM
More...
|
Pharmacopeia Drug Discovery (PCOP)'s First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
5/19/2008 11:15:45 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) to Host First Quarter 2008 Financial Results Webcast and Conference Call
4/23/2008 8:47:28 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference 2008
2/4/2008 7:59:29 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) Announces Third Quarter 2007 Financial Results
11/2/2007 8:30:52 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) to Present at The CIBC World Markets 18th Annual Healthcare Conference
10/23/2007 9:21:32 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) to Host Third Quarter 2007 Financial Results Webcast and Conference Call
10/18/2007 11:42:13 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb (BMY)
10/15/2007 8:47:31 AM
More...
|
Pharmacopeia Drug Discovery (PCOP) to Present Highlights From the Company's DARA Program at the Tenth International Conference on Endothelin (ET-10)
9/5/2007 10:28:03 AM
More...
|
|